• Explore /
  • Poster
  • / A randomized phase II study comparing cabazitaxel/prednisone to cabazitaxel alone in docetaxel-pretreated men with metastatic castration resistant prostate cancer (mCRPC): The CABACARE trial.

A randomized phase II study comparing cabazitaxel/prednisone to cabazitaxel alone in docetaxel-pretreated men with metastatic castration resistant prostate cancer (mCRPC): The CABACARE trial.

Abstract Poster

Authors

null

Carlo Buonerba

Federico II University, Naples, Italy

Carlo Buonerba , Francesco Grillone , Sabrina Rossetti , Lorenzo Livi , Mario Scartozzi , Pierosandro Tagliaferri , Dario Bruzzese , Luca Scafuri , Vittorio Riccio , Ferdinando Costabile , Davide Bosso , Simona Iaccarino , Gaetano Facchini , Simone Carrano , Michela Izzo , Michele Caraglia , Sabino De Placido , Giuseppe di Lorenzo

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Advanced Disease

Clinical Trial Registration Number

2016-005251-25

Citation

J Clin Oncol 37, 2019 (suppl 7S; abstr TPS345)

DOI

10.1200/JCO.2019.37.7_suppl.TPS345

Abstract #

TPS345

Poster Bd #

N21

Abstract Disclosures

Similar Posters

First Author: Carlo Buonerba

First Author: Sumit Kumar Subudhi

First Author: Karim Fizazi

First Author: Susan F. Slovin